• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: Biosense Webster Inc QDOT MICRO; Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

Biosense Webster Inc QDOT MICRO; Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation Back to Search Results
Catalog Number D139504
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Codes Cardiac Arrest (1762); Asystole (4442)
Date of Event 08/26/2026
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that a patient underwent an atrial fibrillation ablation with a qdot micro catheter and the patient experienced cardiac arrest/asystole that required cpr (cardiopulmonary resuscitation).After ablating, (pulmonary vein isolation--posterior wall with the farawave and cavotricuspid isthmus with the qdot), the patient's heart stopped with a rapid drop in blood pressure.Cpr was started and a tee (transesophageal echocardiogram) was performed--no effusion was noted.The patient's vital signs eventually returned to baseline after about 10 minutes.The patient fully recovered but required extended hospitalization (the doctor wanted to keep the patient overnight to monitor him).The event occurred after catheters and sheaths were removed at the end of the procedure.The physician believes it was an allergic reaction to protamine.
 
Additional Manufacturer Narrative
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO
Common Device Name
Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation
Manufacturer (Section D)
Biosense Webster Inc
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
Biosense Webster Inc (Juarez)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
katie seppa
31 technology dr
irvine, CA 92618
+1(513)337-8052
MDR Report Key50872908
Report Number3013300026-2026-03130
Device Sequence Number9379827
Product Code OAE
UDI-Device Identifier10846835016741
UDI-Public(01)10846835016741(17)290429(10)31919620L
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P210027
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Type of Report Initial
Report Date (Section B) 09/23/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberD139504
Device Lot Number31919620L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/26/2026
Initial Report FDA Received Date09/23/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured04/30/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention; Life Threatening;
Patient SexMale
-
-